TG Therapeutics (TGTX) PT Lowered to $20 at Ladenburg Thalmann
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $20.00 (from $47.00) while maintaining a Buy rating.
Ladenburg Thalmann analyst Matthew Kaplan lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $20.00 (from $47.00) while maintaining a Buy rating.